We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$138M
AUM Growth
-$9.31M
Cap. Flow
-$9.71M
Cap. Flow %
-7.03%
Top 10 Hldgs %
24.49%
Holding
191
New
28
Increased
25
Reduced
77
Closed
34

Top Buys

Rank Stock Value
1
TSN icon
Tyson Foods
TSN
+$935K
2
MET icon
MetLife
MET
+$903K
3
FOX icon
Fox Class B
FOX
+$867K
4
CAG icon
Conagra Brands
CAG
+$770K
5
ELAN icon
Elanco Animal Health
ELAN
+$663K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.8M
2
EL icon
Estee Lauder
EL
+$1.41M
3
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$1.11M
4
MDC
M.D.C. Holdings, Inc.
MDC
+$1.09M
5
UAL icon
United Airlines
UAL
+$915K

Sector Composition

Rank Sector Weight
1 Healthcare 19.04%
2 Consumer Staples 15.56%
3 Industrials 14.75%
4 Technology 13.52%
5 Financials 12.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TELL
151
DELISTED
Tellurian Inc.
TELL
$91K 0.07%
11,000
– –
AKAM icon
152
Akamai
AKAM
$15.2B
– –
-5,850
Closed -$469K
ALB icon
153
Albemarle
ALB
$13.2B
– –
-3,200
Closed -$225K
ALK icon
154
Alaska Air
ALK
$4.46B
– –
-3,850
Closed -$246K
AMGN icon
155
Amgen
AMGN
$204B
– –
-9,762
Closed -$1.8M
AVGO icon
156
Broadcom
AVGO
$1.64T
– –
-8,000
Closed -$230K
AZTA icon
157
Azenta
AZTA
$1.48B
– –
-9,700
Closed -$376K
BAX icon
158
Baxter International
BAX
$12.2B
– –
-6,350
Closed -$520K
BDX icon
159
Becton Dickinson
BDX
$50.7B
– –
-3,347
Closed -$823K
BMRN icon
160
BioMarin Pharmaceuticals
BMRN
$12.7B
– –
-3,150
Closed -$270K
CP icon
161
Canadian Pacific Kansas City
CP
$77.3B
– –
-4,275
Closed -$201K
EBAY icon
162
eBay
EBAY
$47.3B
– –
-10,500
Closed -$415K
EW icon
163
Edwards Lifesciences
EW
$49.9B
– –
-5,250
Closed -$323K
FN icon
164
Fabrinet
FN
$14B
– –
-16,008
Closed -$795K
FTNT icon
165
Fortinet
FTNT
$126B
– –
-49,500
Closed -$761K
HCA icon
166
HCA Healthcare
HCA
$91.8B
– –
-5,000
Closed -$676K
HEES
167
DELISTED
H&E Equipment Services
HEES
– –
-15,301
Closed -$445K
HQY icon
168
HealthEquity
HQY
$7.98B
– –
-4,240
Closed -$277K
KEY icon
169
KeyCorp
KEY
$22.9B
– –
-31,395
Closed -$557K
KIM icon
170
Kimco Realty
KIM
$15.5B
– –
-16,500
Closed -$305K
MAR icon
171
Marriott International
MAR
$88.2B
– –
-1,450
Closed -$203K
NEE icon
172
NextEra Energy
NEE
$170B
– –
-5,600
Closed -$287K
NKTR icon
173
Nektar Therapeutics
NKTR
$2.3B
– –
-740
Closed -$395K
NOC icon
174
Northrop Grumman
NOC
$75.3B
– –
-1,100
Closed -$355K
NVDA icon
175
NVIDIA
NVDA
$5.19T
– –
-64,400
Closed -$264K
4 5 6
7
8

Similar funds

GFP
Guardian Financial Partners Orange, California $257M AUM 19.03% 1-Year Est. Return
UI
Untitled Investments New York $257M AUM 15.31% 1-Year Est. Return
HWA
HMV Wealth Advisors Shreveport, Louisiana $257M AUM 26.62% 1-Year Est. Return
LGW
Leslie Global Wealth Itasca, Illinois $257M AUM 23.12% 1-Year Est. Return
TCG
Transcendent Capital Group Edmond, Oklahoma $257M AUM 25.68% 1-Year Est. Return
6F
626 Financial Portage, Michigan $257M AUM 22.23% 1-Year Est. Return
MCP
Miller Capital Partners Troy, Michigan $257M AUM
BWM
Birchcreek Wealth Management Miami Township, Ohio $257M AUM 34.72% 1-Year Est. Return

New England Research & Management's Q3 2019 Portfolio in Review

As of Q3 2019, New England Research & Management held 191 positions worth $138M, down 6.3% from $147M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management withdrew a net $9.71M in Q3 2019, closing 34 positions and reducing 77 holdings. Its most notable exit was Amgen, an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, New England Research & Management opened a new position in Tyson Foods worth $948K.

  • New England Research & Management's largest Q3 2019 buy was Tyson Foods: 11,000 shares worth $948K.
  • New England Research & Management added most to Elanco Animal Health in Q3 2019, an estimated $663K increase.
  • New England Research & Management's biggest Q3 2019 reduction was Estee Lauder, cutting an estimated $1.41M.
  • New England Research & Management fully exited Amgen in Q3 2019, selling an estimated $1.8M.
  • New England Research & Management's ten largest holdings make up 24% of its $138M portfolio in Q3 2019.
  • New England Research & Management opened 28 new positions and closed 34 in Q3 2019.
  • New England Research & Management's portfolio value fell 6.3% quarter-over-quarter to $138M.

Based on New England Research & Management's 13F filing for Q3 2019, filed 4 Nov 2019.